TacticScaleWhat Huapont Life Sciences (华邦健康) Does & How It Makes Money (002004.SZ)
Updated October 2026 · reflects Huapont Life Sciences's latest reported financials
Chinese maker of dermatology drugs and crop-protection pesticides. It earns revenue by manufacturing and selling pharmaceutical preparations and active ingredients, along with pesticide technicals, intermediates and formulations, to domestic and overseas customers.
How Huapont Life Sciences makes money
It earns revenue by manufacturing and selling pharmaceutical preparations and active ingredients, along with pesticide technicals, intermediates and formulations, to domestic and overseas customers. Additional income comes from GLP registration technical services, drug-promotion agency work, fine chemicals and polymer materials, and tourism services.
What Huapont Life Sciences does
Huapont Life Sciences (002004.SZ), founded in 1992 and headquartered in Chongqing, is a diversified Chinese group built around two core businesses: medicine and agrochemicals. Its pharmaceutical arm produces both finished preparations and raw materials, with therapeutic coverage spanning dermatology, tuberculosis, anti-infectives, respiratory, oncology and cardiovascular, complemented by health-management products and agency promotion of preparation products. The agrochemical arm supplies pesticide technicals, intermediates and formulations, and offers GLP registration technical services to customers in China and abroad. Around these two pillars the company also operates fine chemicals and polymer materials R&D and manufacturing, plus a tourism services business. Formerly known as Huapont-Nutrichem Co., Ltd., it adopted its current name in September 2015, signalling a shift in identity toward life sciences while retaining its agricultural-inputs heritage — which is why it is still classified under the agricultural inputs industry despite its substantial pharmaceutical operations.
Products & services
- Dermatology (skin disease) medicines
- Anti-tuberculosis and anti-infection drugs
- Respiratory, anti-tumor and cardiovascular drugs
- Pharmaceutical raw materials (APIs)
- Pesticide technicals, intermediates and formulations
- GLP registration technical services
- Fine chemicals and polymer materials
- Tourism services
华邦健康是做什么的？
华邦健康（002004.SZ）成立于1992年，总部位于重庆，是一家以医药和农药为两大核心的多元化企业。医药板块同时经营药品制剂和原料药，产品覆盖皮肤病、结核病、抗感染、呼吸、抗肿瘤和心血管等治疗领域，并提供健康管理产品及制剂产品的推广代理服务。农药板块则面向国内外客户提供农药原药、中间体和制剂产品，以及GLP登记技术服务。 围绕这两大主业，公司还从事精细化工产品和高分子材料的研发、生产与销售，并经营旅游服务业务。公司原名华邦颖泰股份有限公司，于2015年9月更名为华邦生命健康股份有限公司，名称变更体现了其向生命健康方向的定位调整，但农化业务仍是重要根基，这也是其在行业分类上仍被归入农用投入品的原因。
What is Huapont Life Sciences worth?
On an owner-earnings DCF, Huapont Life Sciences's most-likely value is about ¥8 versus a recent price near ¥4 (44% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~¥4) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Huadong Medicine (000963.SZ) · ApicHope Pharmaceutical (300723.SZ) · Anhui Guangxin Agrochemical (603599.SS) · Hybio Pharmaceutical (300199.SZ)